The independent source for health policy research, polling, and news.
201 - 220 of 1,576 Results
Medicare pays hospitals about double what it pays other providers for the same services. The hospital lobby is fighting hard to make sure a switch to "site-neutral payments” doesn't become law.
As science skepticism pervades politics, the Supreme Court will soon consider two cases that seek to define the power of “experts.” Meanwhile, abortion opponents are laying out plans for how Donald Trump, if reelected as president, could effectively curtail abortion even in states where it remains legal. Sandhya Raman of CQ Roll Call, Joanne Kenen of Johns Hopkins University and Politico Magazine, and Sarah Karlin-Smith of the Pink Sheet join Ńîąóĺú´«Ă˝Ň•îl Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Samantha Liss, who reported and wrote the latest Ńîąóĺú´«Ă˝Ň•îl Health News-NPR “Bill of the Month” feature about a husband and wife who got billed for preventive care that should have been fully covered.
Politicians keep talking about fixing primary care shortages. But flawed national data leaves big holes in how to evaluate which policies are effective.
Ńîąóĺú´«Ă˝Ň•îl Health News gives readers a chance to comment on a recent batch of stories.
New Hampshire’s primary election was dominated by voters’ feelings about Donald Trump. But health care remains a concern — and for Democrats, preserving abortion access is a priority.
You’ve probably seen advertising about Medicare Advantage plans. Ńîąóĺú´«Ă˝Ň•îl Health News' Sarah Jane Tribble explains the pros and cons of this insurance option as enrollment in these plans increases.
Health policy during Donald Trump’s tenure was dominated by covid-19 and a failed effort to repeal and replace the Affordable Care Act. His appointments to the Supreme Court led to the end of national abortion rights, and he took steps to increase hospital price transparency and improve care for veterans.
With days to go until a large chunk of the federal government runs out of money needed to keep it operating, Congress is still struggling to find a compromise spending plan. Meanwhile, the Supreme Court agreed to hear — this year — a case that pits federal requirements for emergency treatment against state abortion bans. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Tami Luhby of CNN join Ńîąóĺú´«Ă˝Ň•îl Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews American Medical Association President Jesse Ehrenfeld about the choppy waters facing the nation’s physicians in 2024.
The fifth debate of the 2024 GOP presidential primary season took place days before Iowa Republicans will caucus to determine their pick for the top of the party’s ticket. The front-runner, former President Donald Trump, once again did not participate.
As enrollment in private Medicare Advantage plans grows, so do concerns about how well the insurance works, including from those who say they have become trapped in the private plans as their health declines.
2023 was another busy year in health care. As the covid-19 pandemic waned, policymakers looked anew at long-standing obstacles to obtaining and paying for care in the nation’s health care system. Meanwhile, abortion has continued to be an issue in much of the nation, as states respond to the Supreme Court’s 2022 decision overturning the constitutional right to the procedure. This week, Rachel Cohrs of Stat, Sandhya Raman of CQ Roll Call, and Joanne Kenen of Johns Hopkins University and Politico Magazine join Ńîąóĺú´«Ă˝Ň•îl Health News chief Washington correspondent Julie Rovner to discuss these issues and wrap up the year in health. Also this week, Rovner interviews Ńîąóĺú´«Ă˝Ň•îl Health News’ Jordan Rau about his joint Ńîąóĺú´«Ă˝Ň•îl Health News-New York Times series “Dying Broke.”
Sensing that Republicans are walking into a political minefield by threatening once again to repeal the Affordable Care Act, the Biden administration is looking to capitalize by rolling out a series of initiatives aimed at high drug prices and other consequences of “corporate greed in health care.” Meanwhile, the Supreme Court hears a case that could determine when and how much victims of the opioid crisis can collect from Purdue Pharma, the drug company that lied about how addictive its drug, OxyContin, really was. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Rachana Pradhan of Ńîąóĺú´«Ă˝Ň•îl Health News join Ńîąóĺú´«Ă˝Ň•îl Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann of Ńîąóĺú´«Ă˝Ň•îl Health News’ sister podcast, “An Arm and a Leg,” about his investigation into hospitals suing their patients over unpaid bills.
As open enrollment ends, many people are tuning out. They could wind up with a surprise next year: higher costs and less access to health care providers.
Facing a severe shortage of aides and high costs, people trying to keep aging loved ones at home often cobble together a patchwork of family and friends to help.
Although Republicans have never united behind a replacement for the Affordable Care Act, 2024 GOP presidential front-runner Donald Trump said this week he wants to put the issue back on the national agenda. That delights Democrats, who have won at least two elections partly by defending the now-popular health law. Meanwhile, the Texas Supreme Court takes up a case brought by women who say their pregnancy complications further endangered their health due to the vagueness of Texas’ near-total ban on abortions. Joanne Kenen of Johns Hopkins University and Politico Magazine, Sarah Karlin-Smith of the Pink Sheet, and Victoria Knight of Axios News join Ńîąóĺú´«Ă˝Ň•îl Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Ńîąóĺú´«Ă˝Ň•îl Health News’ Rachana Pradhan, who reported and wrote the latest “Bill of the Month” feature.
The Biden administration wants to crack down on deceptive or misleading Medicare Advantage and drug plan sales tactics. It’s counting on beneficiaries to help catch offenders.
Some hospitals and physician groups are rejecting Medicare Advantage plans over payment rates and coverage restrictions, causing turmoil for patients.
© 2026 KFF